BioMarin to Host Second Quarter 2018 Financial Results Conference Call and Webcast on Thursday, August 2 at 4:30pm ET

SAN RAFAEL, Calif., July 11, 2018 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, August 2, at 4:30 p.m. ET to discuss second quarter 2018 financial results and provide a general business update.

Dial-in Number
U.S. / Canada Dial-in Number: (866) 502-9859
International Dial-in Number: (574) 990-1362
Conference ID: 3364409

Replay Dial-in Number: (855) 859-2056
Replay International Dial-in Number: (404) 537-3406
Conference ID: 3364409

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, A replay of the call will be archived on the site for one week following the call.

About BioMarin
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for patients with serious and life-threatening rare and ultra-rare genetic diseases. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates. For additional information, please visit


    Investors                                  Media

    Traci McCarty                              Debra Charlesworth

    BioMarin Pharmaceutical Inc.               BioMarin Pharmaceutical Inc.

    (415) 455-7558                             (415) 455-7451


View original content with multimedia:

SOURCE BioMarin Pharmaceutical Inc.


Back to news